charles m. rudin, maria catherine pietanza, todd michael bauer, et. al.
Published 8 years ago • 232 plays • Length 7:50Download video MP4
Download video MP3
Similar videos
-
4:44
catherine pietanza: safety, activity and response durability of rovalpituzumab tesirine in sclc
-
0:59
what are the most common medical conditions of pancreatic cancer patients? | prof buechler
-
1:01
lynn cancer institute
-
0:16
memorial cancer institute: you're stronger than cancer
-
7:28
is it cancer?
-
2:35
breast cancer treatment researcher awarded prime minister's prize for science
-
3:44
imagefilm brustzentrum universitätsklinikum heidelberg
-
18:12
michael ammazzalorso, md on pancreatic cancer
-
26:02
machine learning aided discovery of potential biomarkers for cancer diagnosis and prognosis
-
1:00:45
metastatic breast cancer and the tumor microenvironment
-
1:03
the value of immunotherapy in spinal oncology
-
16:34
what matters most to oncology patients?
-
2:50
total commitment to total heart - michael cortelli, md & michele slane - frank sacco video series
-
1:05
the oncologists: a new medscape series
-
2:17
defining future cancer treatments with professor lisa butler | florey 120th anniversary
-
0:59
dr secord on mirvetuximab soravtansine in platinum-sensitive, frα-high ovarian cancer
-
12:32
innovations in cancer research
-
26:18
the impact of cancer treatment on the heart
-
39:57
webinar wednesday -- kidney cancer 101 (3.24.21)